Cisplatin nanoparticles boost abscopal effect of radiation plus anti-PD1 therapy. (3rd March 2021)
- Record Type:
- Journal Article
- Title:
- Cisplatin nanoparticles boost abscopal effect of radiation plus anti-PD1 therapy. (3rd March 2021)
- Main Title:
- Cisplatin nanoparticles boost abscopal effect of radiation plus anti-PD1 therapy
- Authors:
- Wang, Ying
Shen, Na
Wang, Yue
Li, Mo
Zhang, Wanze
Fan, Liwen
Liu, Linlin
Tang, Zhaohui
Chen, Xuesi - Abstract:
- Abstract : CDDP-NPs amplify RT-induced ICD to prime CD8 + T cells and increase their infiltration into non-irradiated tumors by enhancing CXCL10 secretion, eventually augmenting the abscopal effect of RT plus anti-PD1. Abstract : The abscopal effect of radiation therapy (RT) is clinically significant but occurs rarely. Although anti-programmed cell death protein 1 antibody (anti-PD1) is likely to enhance the abscopal effect in patients receiving RT, the incidence rate remains less than 30%. One major limitation is the paucity of CD8 + T cells within non-irradiated tumors. Here, cisplatin (CDDP) loaded poly(l -glutamic acid)- graft -methoxy poly(ethylene glycol) complex nanoparticles (CDDP-NPs) are confirmed to increase CD8 + T cells within non-irradiated tumors and boost the abscopal effect of RT plus anti-PD1, and more strongly than CDDP. Compared to RT and RT + CDDP, RT + CDDP-NPs induced greater immunogenic cell death (ICD) with enhanced proportion of Calreticulin + Lewis lung cancer (LLC) cells (16.47%, 20.53% and 27.03%), along with which more CD8 + T cells were infiltrated into CDDP-NP treated irradiated tumors in the unilateral LLC tumor model. In the bilateral LLC tumor model, RT + CDDP-NPs significantly induced more chemokine (C–X–C motif) ligand 10 (CXCL10) secretion (36.3, 44.19 and 56.37 pg mL −1 ), which corresponded to greater CD8 + T cell infiltration in the non-irradiated tumors (0.19%, 0.20% and 0.72%). Finally, compared to RT + anti-PD1 and RT + anti-PD1 +Abstract : CDDP-NPs amplify RT-induced ICD to prime CD8 + T cells and increase their infiltration into non-irradiated tumors by enhancing CXCL10 secretion, eventually augmenting the abscopal effect of RT plus anti-PD1. Abstract : The abscopal effect of radiation therapy (RT) is clinically significant but occurs rarely. Although anti-programmed cell death protein 1 antibody (anti-PD1) is likely to enhance the abscopal effect in patients receiving RT, the incidence rate remains less than 30%. One major limitation is the paucity of CD8 + T cells within non-irradiated tumors. Here, cisplatin (CDDP) loaded poly(l -glutamic acid)- graft -methoxy poly(ethylene glycol) complex nanoparticles (CDDP-NPs) are confirmed to increase CD8 + T cells within non-irradiated tumors and boost the abscopal effect of RT plus anti-PD1, and more strongly than CDDP. Compared to RT and RT + CDDP, RT + CDDP-NPs induced greater immunogenic cell death (ICD) with enhanced proportion of Calreticulin + Lewis lung cancer (LLC) cells (16.47%, 20.53% and 27.03%), along with which more CD8 + T cells were infiltrated into CDDP-NP treated irradiated tumors in the unilateral LLC tumor model. In the bilateral LLC tumor model, RT + CDDP-NPs significantly induced more chemokine (C–X–C motif) ligand 10 (CXCL10) secretion (36.3, 44.19 and 56.37 pg mL −1 ), which corresponded to greater CD8 + T cell infiltration in the non-irradiated tumors (0.19%, 0.20% and 0.72%). Finally, compared to RT + anti-PD1 and RT + anti-PD1 + CDDP, RT + anti-PD1 + CDDP-NPs significantly inhibited the growth of non-irradiated tumors more forcefully, as indicated by the respective tumor volumes of 1141, 1146 and 585 mm 3 . This is the first study to show that CDDP-NPs can amplify RT-induced immune activation and break through the efficiency limitation of the RT plus anti-PD1 induced abscopal effect. … (more)
- Is Part Of:
- Biomaterials science. Volume 9:Number 8(2021)
- Journal:
- Biomaterials science
- Issue:
- Volume 9:Number 8(2021)
- Issue Display:
- Volume 9, Issue 8 (2021)
- Year:
- 2021
- Volume:
- 9
- Issue:
- 8
- Issue Sort Value:
- 2021-0009-0008-0000
- Page Start:
- 3019
- Page End:
- 3027
- Publication Date:
- 2021-03-03
- Subjects:
- Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://pubs.rsc.org/en/journals/journalissues/bm ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/d1bm00112d ↗
- Languages:
- English
- ISSNs:
- 2047-4830
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2087.724000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 16337.xml